| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Director
2 companies
Ho Carole is a Chief Medical Officer at Denali Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $5.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 17,500 | $18.72 | $327,589.07 | -95.8% | |
| Jan 4, 2019 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sale+OE | 14,502 | $19.55 | $283,506.05 | -4.6% | |
| Dec 3, 2018 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17,500 | $18.45 | $322,834.10 | -5.6% | |
| Nov 15, 2018 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17,500 | $18.07 | $316,156.75 | -9.5% | |
| Oct 1, 2018 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17,500 | $21.72 | $380,100.00 | -8.7% | |
| Sep 4, 2018 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17,500 | $19.05 | $333,375.00 | -8.0% | |
| Aug 29, 2018 | DNLI Denali Therapeutics Inc. | Chief Medical Officer | Sell | 17,500 | $18.04 | $315,700.00 | -7.4% |